• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

GoodRx Offers 30 Meds Under $30 for Heart Conditions

by Jasmine Pennic 02/15/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
GoodRx Offers 30 Meds Under $30 for Heart Conditions

What You Should Know:

GoodRx, a prescription savings platform, is stepping up to help with a new program offering 30 common heart health medications for under $30 at over 70,000 pharmacies nationwide.

Making Heart Health Affordable

– GoodRx recognizes the financial burden of managing heart disease and aims to improve access to affordable medications. By offering significant discounts on both generic and brand-name drugs, they target conditions like coronary artery disease, high cholesterol, and hypertension.

– GoodRx’s program aims to improve health outcomes and reduce healthcare system strain by making medications more affordable.

Examples of Savings

The following is a sample list of common generic medications used to treat cardiovascular disease that are available for under $30 on GoodRx.

MedicationLowest PriceAvg % Savings
ACE Inhibitors
Lisinopril (generic Prinivil and Zestril) $9.2967%
Enalapril (generic Epaned and Vasotec)$15.5475%
Beta Blockers
Carvedilol (generic Coreg)$10.6875%
Metoprolol ER (generic Toprol XL)$11.1574%
Propranolol (generic Inderal)$10.9671%
Calcium Channel Blockers
Amlodipine (generic Amvaz, Katerzia, and Norvasc)$9.1580%
Diltiazem ER (generic Cardizem CD)$13.4374%
Statins
Atorvastatin (generic Lipitor)$10.1083%
Pravastatin (generic Pravachol)$14.5374%
Rosuvastatin (generic Crestor)$10.5791%

Access exclusive discounts and savings on brand-name drugs

GoodRx offers incredible savings on brand-name medications that are often more costly and harder to obtain:

MedicationSavings*
EntrestoPay as little as $10 for up to a 90-day supply
JardiancePay as little as $10 per month
LodocoPay as little as $30 for up to a 90-day supply
OzempicPay as little as $25 per month
RepathaPay as little as $5 per month
SoaanzExclusive discount to save over 70%
Toprol XL Exclusive discount to save up to 51%
Xarelto Pay as little as $10 per fill

*May require private or commercial insurance

“Improving access to affordable medications is the most important thing we can do to improve Americans’ heart health. The second most important is ensuring access to helpful, accurate information,” said Karla Robinson, MD, Medical Editor at GoodRx. “Knowledge is power, so we create easy-to-understand content that people can actually use so they are better equipped to minimize the risk of disease, find affordable medications, stick to their treatment plans, and ultimately improve their overall health and wellbeing.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: GoodRx

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |